首页> 外国专利> Peptide derivatives that control thymic stromal lymphopoietin-mediated signal transmission and pharmaceutical compositions for preventing and treating allergic and asthmatic diseases containing the same

Peptide derivatives that control thymic stromal lymphopoietin-mediated signal transmission and pharmaceutical compositions for preventing and treating allergic and asthmatic diseases containing the same

机译:控制胸腺基质淋巴细胞生成素介导的信号传递的肽衍生物以及用于预防和治疗包含其的过敏性和哮喘性疾病的药物组合物

摘要

The present invention relates to a peptide derivative that controls thymic stromal lymphopoietin-mediated signal transmission, and a pharmaceutical composition for preventing and treating allergic and asthmatic diseases including the same, and more specifically, a peptide derivative represented by Formula 1 And a pharmaceutical composition for the prevention and treatment of allergies and asthma diseases containing the same. According to the present invention, a peptide derivative capable of effectively suppressing formation of an inflammatory reaction in allergy or asthma disease and a pharmaceutical composition containing the peptide derivative are provided, and various allergy and asthma diseases are fundamentally prevented or treated using the peptide derivative. be able to.
机译:本发明涉及一种控制胸腺基质淋巴细胞生成素介导的信号传递的肽衍生物,以及用于预防和治疗变应性和哮喘病的药物组合物,更具体地,涉及由式1表示的肽衍生物和用于该方法的药物组合物。过敏和哮喘病的预防和治疗相同。根据本发明,提供了能够有效抑制过敏或哮喘病中的炎症反应的形成的肽衍生物和包含该肽衍生物的药物组合物,并且使用该肽衍生物从根本上预防或治疗了各种过敏和哮喘病。能够。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号